ACRX $2.26 0.05 (2.2%)

    ACRX Profile

    ACRX trades on the NASDAQ.

    MEMBERSHIP
    --
    SECTOR
    Health Care
    MARKET CAPITALIZATION

    $190 Million

    AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The company's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The company has one approved product in the U.S., DSUVIA (sufentanil sublingual tablet) known as DZUVEO in Europe indicated for the management of acute pain, severe enough to require an opioid analgesic for adult patients and one product candidate, Zalviso (sufentanil sublingual tablet system, SST system being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings.

    ACRX Earnings

    EPS

    -0.16

    P/E

    --

    Q2 Earnings for Apr, May & Jun

    Mon, Aug 5, 2019

    Since Earnings Report

    ACRX -6.6%

    Q3 Earnings for Jul, Aug & Sep

    Wed, Nov 6, 2019

    Since Earnings Report

    ACRX +11.3%

    ACRX Dividend

    Dividend Yield

    0.00%

    Dividend Rate

    $0.00

    Ex-Dividend Date

    --

    Dividend Pay Date

    --

    Dividend Frequency

    --

    Dividend Payments

    --

    ACRX Charts

    52WL $1.64
    52WH $4.09
    All-Time $13.64


    ACRX Industry Competitors


    MEDICAL EQUIPMENT & DEVICES
    Abbott Laboratories
    Medtronic
    Thermo Fisher Scientific
    Danaher
    Stryker
    Becton Dickinson
    Intuitive Surgical
    Boston Scientific
    Edwards Lifesciences
    Illumina



    Symbol MC DY Price Day YTD
    ACRX $0.19 0.00% $2.26 -2.2% -8.9%






        TOP    




    info@symbolsurfing.com


    Symbol Surfing

    ©2019 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy